Bank of America’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bank of America’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,800,000	Closed	-$43.8M	–	8300
2025 Q2	$43.8M	Sell	1,800,000 -916,400	-34%	-$20.1M	﹤0.01%	1813
2025 Q1	$56.4M	Buy	2,716,400 +2,216,400	+443%	+$55.7M	﹤0.01%	1479
2024 Q4	$11.8M	Buy	500,000 +100,000	+25%	+$2.46M	﹤0.01%	2778
2024 Q3	$10.2M	Sell	400,000 -50,000	-11%	-$1.27M	﹤0.01%	3041
2024 Q2	$10.6M	Buy	+450,000	New	+$11.4M	﹤0.01%	2897
2022 Q4	–	Sell	-200,000	Closed	-$6.57M	–	8208
2022 Q3	$6.57M	Buy	200,000 +44,700	+29%	+$1.64M	﹤0.01%	3051
2022 Q2	$4.89M	Sell	155,300 -19,700	-11%	-$689K	﹤0.01%	3418
2022 Q1	$8.04M	Buy	+175,000	New	+$8.34M	﹤0.01%	3077
2021 Q3	–	Sell	-211,100	Closed	-$19.5M	–	8089
2021 Q2	$19.5M	Buy	211,100 +161,100	+322%	+$13.7M	﹤0.01%	2153
2021 Q1	$4.44M	Buy	+50,000	New	+$4.96M	﹤0.01%	3519

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Bank of America's ARKG Position: Q1 2026 in Review

Bank of America reduced its ARK Genomic Revolution ETF (ARKG) stake by 35% in Q1 2026, selling an estimated $14.1M and leaving 873,702 shares worth $23.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2268.

Bank of America first reported a position in ARKG in Q1 2018 and has held it in 33 quarters since. The position peaked at $234M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Bank of America held 873,702 shares of ARK Genomic Revolution ETF worth $23.1M as of Q1 2026.
Bank of America sold 480,026 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $14.1M.
ARK Genomic Revolution ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2268 holding.
Bank of America first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 33 quarters since.
Bank of America's ARK Genomic Revolution ETF position peaked at $234M in Q2 2021.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.